![Selexipag Active Metabolite-d7 [1265295-20-2] Selexipag Active Metabolite-d7 [1265295-20-2]](https://www.targetmol.com/group3/M00/13/92/CgoaEWZNa4SELGg9AAAAABd0VI4879.png)
Selexipag Active Metabolite-d7 [1265295-20-2]
TMIH-0519
Overview
- SupplierTargetMol Chemicals
- Product NameSelexipag Active Metabolite-d7 [1265295-20-2]
- Delivery Days Customer16
- CertificationResearch Use Only
- Molecular FormulaC25H22D7N3O3
- Molecular Weight426.56
- Scientific DescriptionSelexipag Active Metabolite-d7 is a deuterated compound of Selexipag Active Metabolite. Selexipag Active Metabolite has a CAS number of 475085-57-5. MRE-269 is an orally available and long-acting prostacyclin receptor agonist prodrug. MRE-269 is used for the treatment of pulmonary arterial hypertension. MRE-269 is an active metabolite of Selexipag (S253150).
- SMILES[2H]C([2H])([2H])C([2H])(N(CCCCOCC(O)=O)C1=CN=C(C2=CC=CC=C2)C(=N1)C1=CC=CC=C1)C([2H])([2H])[2H]
- Storage Instruction-20°C
- UNSPSC12352200